Nanomedicine Therapeutics Holds Inaugural Online Editorial Board Meeting to Advance Global Development Strategy

On April 28, 2026, Nanomedicine Therapeutics successfully held its inaugural online Editorial Board Meeting via a virtual conferencing platform, organized by the journal's Editorial Office. The meeting brought together 36 Associate Editors, Editorial Board Members, and Youth Editorial Board Members from China, the United States, Portugal, Israel, Singapore, and other countries and regions. Editor-in-Chief Prof. Xiangyang Shi actively participated throughout the meeting and provided strategic guidance on the journal's future development.

The meeting served as an important platform for in-depth discussions on the journal's positioning, academic quality assurance, manuscript management, international collaboration, and brand development. Participants exchanged valuable insights and recommendations aimed at strengthening the journal's academic influence and global visibility.

In his remarks, Prof. Shi emphasized that Nanomedicine Therapeutics is an international, peer-reviewed, open access interdisciplinary journal dedicated to building a high-quality and high-impact academic platform in the field of nanomedicine and precision therapeutics. The journal focuses on frontier research at the intersection of nanotechnology and biomedical therapeutics, covering areas such as nanoparticle design, drug delivery systems, disease diagnosis, theranostics, and translational nanomedicine. Through rigorous academic standards and an international development strategy, the journal aims to continuously enhance its global academic presence.

Prof. Shi also introduced the journal's publishing vision and long-term development plans. Nanomedicine Therapeutics will publish a broad range of article types, including original research articles, reviews, perspectives, short communications, and commentaries, with the goal of promoting the integration of fundamental nanomedicine research and clinical translation. To ensure both academic rigor and publication efficiency, the journal has established a standardized and efficient editorial workflow jointly coordinated by the Editorial Office and the Editorial Board.

During the discussion session, attendees actively contributed valuable suggestions regarding manuscript solicitation, engagement with early-career researchers, Special Issue planning, international cooperation, and academic branding. The discussions reflected the Editorial Board's strong commitment to supporting the journal's long-term development and internationalization. Concluding the meeting, Prof. Shi expressed his heartfelt gratitude to all board members for their support and constructive input, and outlined the journal's priorities for the next stage of development.

The successful convening of this inaugural Editorial Board Meeting marks an important milestone in the development of Nanomedicine Therapeutics. The meeting laid a solid foundation for the journal's future publication strategy, academic quality standards, and international outreach efforts. Moving forward, the journal will continue to pursue a high-quality, internationalized, and selective publishing strategy, aiming to become a valuable academic platform in the field of nanomedicine and precision therapeutics.

Attendees of the Meeting

Editor-in-Chief

Xiangyang Shi, Donghua University, China

Associate Editors

Hangrong Chen, Chinese Academy of Sciences, China
Yu Chen, Shanghai University, China
Gang Han, University of Massachusetts Medical School, United States
Jingchao Li, Donghua University, China
Kui Luo, Sichuan University, China
Rachela Popovtzer, Bar-Ilan University, Israel
Ruibing Wang, University of Macau, China

Editorial Board Members

Qian Chen, Tongji University, China
Yunlu Dai, University of Macau, China
Changming Dong, Shanghai Jiao Tong University, China
Shasha He, Xiamen University, China
Xin Li, City University of Hong Kong, China
Yuxia Luan, Shandong University, China
Joao Rodrigues, University of Madeira, Portugal
Yi Wang, Donghua University, China
Tao Yi, Donghua University, China
Meng Zheng, Henan University, China
Jianhua Zou, National University of Singapore, Singapore

Youth Editorial Board Members

Evgeny Apartsin, Université de Bordeaux, France
Xiaojun Cai, Wenzhou Medical University, China
Ying Chen, Rowan University, United States
Bingyang Chu, Sichuan University, China
Xiaoqiu Dou, Shanghai Jiao Tong University, China
Zhong Guo, Beijing Normal University, China
Wei Jiang, Zhengzhou University, China
Jie Lin, Chinese Academy of Sciences, China
Jifu Mao, Donghua University, China
Yangbao Miao, University of Electronic Science and Technology of China, China
Jing Mu, The Chinese University of Hong Kong, China
Shaojun Peng, Beijing Institute of Technology, China
Shuo Shi, Tongji University, China
Congzhou Wang, South Dakota School of Mines & Technology, United States
Peng Wei, Donghua University, China
Qin Zhang, Shanghai University, China
Benqing Zhou, Shantou University, China

Editor: Tina Li
Language Editor: Catherine Yang
Production Editor: Ting Xu
Respectfully Submitted by the Editorial Office of Nanomedicine Therapeutics